European Medicines Agency recommends restricting use of Multaq

View source ↗

Summary

The EMA recommends restricting the use of Multaq (dronedarone) due to safety concerns and safer alternatives; explicit usage restrictions and patient monitoring…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Multaq (dronedarone)